Melanotan II
Sexual Health

Melanotan II

Melanocortin Receptor Agonist

A melanocortin receptor agonist prescribed at SSK Longevity in Newport Beach, California, for melanocortin pathway protocols including pigmentation and sexual health.

DailySubcutaneous Injection
85%+Visible Skin Darkening
5,000+Patients Treated at SSK Longevity
10,000+Longevity Consultations
About Melanotan II

A Broad-Spectrum Melanocortin Pathway Peptide

Melanotan II is a synthetic peptide that activates multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R) — a broader pathway profile than PT-141, which acts primarily on MC4R. Melanotan II's broader receptor profile gives it activity across multiple physiologic pathways including melanin synthesis (pigmentation), sexual response, and appetite regulation.

At SSK Longevity in Newport Beach, Melanotan II is prescribed off-label under physician supervision and compounded under Sherry Kelishadi, Pharm.D.'s direct pharmacy oversight. Dr. Sean Kelishadi, MD FACS integrates Melanotan II into protocols for Newport Beach, Costa Mesa, Irvine, and broader Orange County patients in carefully selected clinical contexts.

Melanotan II
The Mechanism

Why Melanotan II Acts Broadly Across Melanocortin Receptors

Melanotan II activates multiple melanocortin receptor subtypes simultaneously. This broader receptor profile produces effects across pigmentation, sexual response, and appetite-regulation pathways — making patient selection and protocol design particularly important.

1

MC1R Activation (Pigmentation)

Melanotan II activates the MC1 receptor in skin melanocytes, stimulating melanin production. This is the most well-known effect of the compound.

2

MC3R / MC4R Activation (Sexual & Metabolic)

Activation of MC3R and MC4R in the central nervous system contributes to sexual response and modulates appetite — overlapping with PT-141's primary mechanism.

3

Broad Receptor Profile

Compared to PT-141's more selective MC4R activity, Melanotan II's broader profile produces effects across multiple pathways simultaneously, requiring careful patient selection.

Melanotan II mechanism
Melanocortin Pathway Compounding

Melanotan II, Compounded Under Strict Patient Selection

Every Melanotan II protocol at SSK Longevity Newport Beach is compounded under Sherry Kelishadi, Pharm.D.'s direct review. Patient selection, dose pacing, and complementary protocol layering are evaluated individually for each patient before any Melanotan II is dispensed.

Newport Beach, Costa Mesa, Irvine, and Orange County patients receive a Melanotan II protocol calibrated to their specific clinical context, goals, and medical history.

Individual results are not guaranteed and may vary from person to person.

PERSONALIZED MELANOTAN II PROTOCOL
Let's get started.
  • Personalized lab review and metabolic assessment
  • Compounded under Pharm.D. supervision in Newport Beach
  • Individualized dose protocols tailored to your physiology
  • Drug interaction review before anything is dispensed
  • Direct physician access throughout treatment
  • Coordinated care with complementary protocols when appropriate
Book Consultation
Patient selection matters substantially with Melanotan II. Comprehensive evaluation required before initiation.
Peer & Alternative Peptides

Peptides Compared To Or Considered Alongside Melanotan II

Patients on Melanotan II in Newport Beach often layer with sexual health protocols or hormonal optimization in carefully selected clinical contexts.

SSK Longevity Peptide Therapy
Layered Melanocortin Protocols

Peptide Therapy Considered Alongside Melanotan II

Melanotan II is rarely the whole protocol. SSK Longevity Newport Beach patients commonly layer it with sexual health protocols or hormonal optimization in carefully selected clinical contexts. Sherry Kelishadi, Pharm.D. coordinates every combined protocol individually before dispensing.

Pair with TRT or HRT for hormonal layering
Layer with growth peptides for longevity depth
Stack with mitochondrial peptides for cellular support
Coordinated planning across all longevity protocols
Ask About Peptides
Clinical Benefits

Melanotan II Benefits at SSK Longevity in Newport Beach, CA

Melanotan II melanocortin pathway peptide therapy at SSK Longevity in Newport Beach activates a broader receptor profile than PT-141, with effects across pigmentation, sexual response, and appetite-regulation pathways. Compounded under Pharm.D. oversight in carefully selected clinical contexts for patients across Newport Beach, Costa Mesa, Irvine, Laguna Beach, Huntington Beach, and Orange County, Melanotan II protocols require thorough patient evaluation. Below are the multi-pathway outcomes Newport Beach Melanotan II patients consistently report.

01

Multi-Pathway Melanocortin Activity

Melanotan II's broader receptor profile produces effects across pigmentation, sexual response, and appetite-regulation pathways simultaneously.

02

Pigmentation Effects

Melanotan II's activation of MC1R in skin melanocytes is its most well-known effect, with pigmentation changes typically observable during protocol cycles.

03

Sexual Response Pathway Activity

MC3R and MC4R activation contributes to sexual response, overlapping with PT-141's mechanism though through a broader receptor profile.

04

Physician-Supervised Access

Melanotan II patients at SSK Longevity receive comprehensive medical oversight, drug interaction screening, and Pharm.D.-supervised compounding — particularly important given the broader receptor profile.

05

Appetite-Modulating Activity

Activation of MC4R modulates appetite-regulation pathways, with potential relevance for some patients in carefully selected contexts.

06

Layered With Hormonal Optimization

Melanotan II commonly integrates with broader hormonal protocols when clinically appropriate.

Strict Patient Selection

Who Is The Right Candidate For Melanotan II?

Melanotan II at SSK Longevity Newport Beach is appropriate for adults seeking medically supervised peptide therapy with physician oversight, lab-driven protocol design, and Pharm.D.-supervised compounding. Patients pursuing this protocol typically fit one or more of the profiles below.

Adults seeking melanocortin pathway protocols under physician supervision
Patients with specific clinical contexts where multi-pathway melanocortin activity is appropriate
Individuals comfortable with comprehensive informed-consent discussions
Adults open to a daily injection cadence during protocol cycles
Patients pursuing comprehensive sexual health protocols with melanocortin layering
Adults with realistic expectations about the broader receptor profile
Newport Beach, Costa Mesa, and Irvine patients seeking ongoing physician oversight
Patients willing to commit to careful clinical evaluation and follow-up
Protocol Design

How Melanotan II Therapy Is Designed at SSK Longevity

1

Comprehensive Consultation

Medical history, skin assessment, and detailed discussion of multi-pathway effects with the SSK Longevity team in Newport Beach.

2

Personalized Protocol

Melanotan II dose, injection cadence, and protocol length calibrated to your physiology and clinical context.

3

Pharmacist Compounding

Sherry Kelishadi, Pharm.D. oversees every Melanotan II vial dispensed by SSK Longevity.

4

Ongoing Clinical Oversight

Scheduled follow-ups, skin monitoring, and protocol adjustments calibrated to your response over time.

How Melanotan II Therapy Is Designed at SSK Longevity
Melanocortin Pathway Safety

Melanotan II Safety, Skin Considerations, and Patient Selection

Melanotan II therapy under proper medical supervision has a well-characterized safety profile, but real considerations deserve direct discussion before any Newport Beach patient begins a protocol.

  • Common side effects during early dosing Nausea (particularly during early dosing), facial flushing, and pigmentation changes in moles or freckles are most commonly reported.
  • Skin and pigmentation considerations Patients with significant moles, atypical nevi, or personal/family history of melanoma require careful evaluation. In many cases Melanotan II is not appropriate.
  • Skin monitoring is essential Skin monitoring during protocol cycles is essential. Any new or changing pigmented lesions require evaluation.
  • Drug interactions reviewed individually Drug interactions with other peptides and medications are reviewed before any protocol begins.
  • Not appropriate during pregnancy or breastfeeding Melanotan II is not used during pregnancy or breastfeeding. Adequate planning is required for patients of reproductive age.
  • Compounded Melanotan II is not FDA-approved Melanotan II is not FDA-approved for any indication. Physician oversight is required throughout treatment.
Patient Reviews

What patients actually say.

★★★★★

"SSK was the first clinic to actually evaluate me thoroughly before prescribing. The skin assessment and informed-consent discussion mattered."

Patient name withheld
Melanotan II Patient, Newport Beach
★★★★★

"Dr. Kelishadi was direct about which patients are appropriate candidates. I appreciated the honesty rather than a generic prescription."

Patient name withheld
Melanotan II Patient, Costa Mesa
★★★★★

"The level of clinical oversight was exactly what I wanted. Sherry calibrated my protocol carefully."

Patient name withheld
Melanotan II Patient, Irvine
Clinical Perspective

From Our Founders

"
Melanotan II is a peptide that requires careful patient selection. Its broad melanocortin receptor profile means it should never be prescribed casually — particularly given the skin and pigmentation considerations. Patient evaluation, informed consent, and ongoing skin monitoring are essential.
Dr. Sean Kelishadi, MD FACS
Dr. Sean Kelishadi, MD FACS
Co-Founder, Medical Director
"
Compounded Melanotan II requires both precise pharmacy work and rigorous patient evaluation. Every vial we dispense at SSK Longevity reflects that level of pharmacist involvement, with skin and dermatologic considerations central to the protocol design.
Sherry Kelishadi, Pharm.D.
Sherry Kelishadi, Pharm.D.
Clinical Pharmacist, Co-Founder
What Patients Want to Know

Melanotan II FAQ for Newport Beach & Orange County

What is Melanotan II?

Melanotan II is a synthetic peptide that activates multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R), producing effects across pigmentation, sexual response, and appetite-regulation pathways.

Is Melanotan II FDA-approved?

No. Melanotan II is not FDA-approved for the indications described on this page. It is prescribed off-label under physician supervision and compounded under physician oversight at SSK Longevity in Newport Beach.

How is Melanotan II different from PT-141?

PT-141 (bremelanotide) is more selective for MC4R, while Melanotan II activates multiple melanocortin receptors more broadly. PT-141 is typically more focused on sexual response; Melanotan II's broader profile produces effects across additional pathways.

Who is not a candidate for Melanotan II?

Patients with significant moles, atypical nevi, or personal/family history of melanoma require careful evaluation; in many cases Melanotan II is not appropriate. Comprehensive skin assessment is part of every initial evaluation at SSK Longevity.

What are the most common side effects?

Nausea (particularly during early dosing), facial flushing, and pigmentation changes in moles or freckles are most commonly reported. Skin monitoring during protocol cycles is essential.

How is Melanotan II injected?

Melanotan II is administered as a subcutaneous injection. Cadence and dose are calibrated to your individualized protocol.

How long is a typical protocol?

Protocol structure is highly individualized. Length, dose, and cadence depend on clinical context and patient response.

Where is SSK Longevity located?

SSK Longevity is in Newport Beach, California, at 500 Superior Avenue, Suite 340 — serving patients across Orange County including Costa Mesa, Irvine, Huntington Beach, and Laguna Beach.

Medical Disclaimer

Melanotan II is not FDA-approved for the indications described on this page. It is prescribed off-label under physician supervision and compounded under physician oversight. The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapy requires physician evaluation, comprehensive laboratory testing, and ongoing clinical oversight. Compounded peptide therapy is generally an out-of-pocket service and is not typically covered by insurance. Payment options and financing are available. Individual results are not guaranteed and may vary from person to person. All treatments are administered under the supervision of a licensed physician.

Get In Touch

Let's Get Started.